Growing community of inventors

Copenhagen, Denmark

Peter Thygesen

Average Co-Inventor Count = 6.28

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 64

Peter ThygesenHelle Demuth (2 patents)Peter ThygesenOle Hvilsted Olsen (1 patent)Peter ThygesenJens Breinholt (1 patent)Peter ThygesenNils Langeland Johansen (1 patent)Peter ThygesenKjeld Madsen (1 patent)Peter ThygesenLars Thim (1 patent)Peter ThygesenNiels Christian Kaarsholm (1 patent)Peter ThygesenJianhe Chen (1 patent)Peter ThygesenSusanne Bang (1 patent)Peter ThygesenChristine Bruun Schiødt (1 patent)Peter ThygesenLeif Noerskov-Lauritsen (1 patent)Peter ThygesenBirgitte Koch Michelsen (1 patent)Peter ThygesenAnette Sams Nielsen (1 patent)Peter ThygesenChristine Brunn Schioedt (1 patent)Peter ThygesenLeif Nørskov-Lauritsen (1 patent)Peter ThygesenPeter Thygesen (3 patents)Helle DemuthHelle Demuth (4 patents)Ole Hvilsted OlsenOle Hvilsted Olsen (43 patents)Jens BreinholtJens Breinholt (28 patents)Nils Langeland JohansenNils Langeland Johansen (19 patents)Kjeld MadsenKjeld Madsen (19 patents)Lars ThimLars Thim (18 patents)Niels Christian KaarsholmNiels Christian Kaarsholm (12 patents)Jianhe ChenJianhe Chen (7 patents)Susanne BangSusanne Bang (6 patents)Christine Bruun SchiødtChristine Bruun Schiødt (4 patents)Leif Noerskov-LauritsenLeif Noerskov-Lauritsen (3 patents)Birgitte Koch MichelsenBirgitte Koch Michelsen (3 patents)Anette Sams NielsenAnette Sams Nielsen (2 patents)Christine Brunn SchioedtChristine Brunn Schioedt (1 patent)Leif Nørskov-LauritsenLeif Nørskov-Lauritsen (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novo Nordisk A/s (2 from 1,777 patents)

2. Novo Nordisk Healthcare Ag (1 from 88 patents)


3 patents:

1. 9211342 - Stable growth hormone compounds resistant to proteolytic degradation

2. 8513192 - Stable growth hormone compounds resistant to proteolytic degradation

3. 7411039 - GLP-2 compounds, formulations, and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/27/2025
Loading…